MedTrace Logo

KOmparison Study KOmparison Study

NCT02039128 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2014-07-29

No results posted yet for this study

Summary

In this double blind, placebo controlled, parallel group study, the relative uptake of 1g/d krill oil in comparison to 1g/d fish oil in healthy female and male adults will be assessed.

Primary objective is to determine if a 12 week supplementation with krill oil increases tissue levels in erythrocytes (omega-3 index) significantly more than fish oil after dose adjustments to EPA and DHA levels.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Krill oil or Fish oil

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • Aker BioMarine Human Ingredients AS

    lead INDUSTRY

Principal Investigators

  • Trygve Bergeland, PhD · Aker BioMarine Human Ingredients AS

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02039128 on ClinicalTrials.gov